Aaron T. Wild, MD

Aaron T. Wild, MD

workRadiation Oncologist
location_onRotates to multiple locations

About Dr. Wild

Licensure

New York State Medical License #281089

National Provider Identification # 124397328

National Board of Medical Examiners Step I, Step II CS, Step II CK, and Step III

Professional Organizations

Radiological Society of North America (RSNA)

American College of Radiology (ACR)

New York Roentgen Society (NYRS)

American Society for Radiation Oncology (ASTRO)

American College of Radiation Oncology (ACRO)


Awards & Affiliations


Education

Memorial Sloan Kettering Cancer Center

2015 — 2019

New York, New York

Resident, Radiation Oncology
Chief Resident: 07/2018 - 06/2019

Memorial Sloan Kettering Cancer Center

2014 — 2015

New York, New York

Transitional Year Internship

Johns Hopkins University School of Medicine

2008 — 2014

Baltimore, Maryland

Doctor of Medicine

Yale University

2004 — 2008

New Haven, Connecticut

B.A., Molecular Biophysics & Biochemistry


Publications

Find Dr. Wild’s full list of publications on PubMed here.


Selected Meeting Presentations

  • Wild AT, Wang Y, Wu W, Haddock SL, Chan TA. Exploitation of 2-hydroxyglutarate-mediated deficiency in homologous recombination with PARP inhibition to achieve radiosensitization in IDH-mutant tumors. Oral presentation at the 2018 ASTRO Annual Meeting, San Antonio, TX, October 21-24, 2018.
  • Leeman JE, Shepherd A, Wild A, Imber B, Pei X, Gelb E, Travis W, Adusumilli P, Jones D, Isbell J, Chaft J, Wu A, Rimner A. Tumor spread through airspaces and histologic subtype predict outcomes following post-operative radiotherapy for locally advanced lung adenocarcinoma. Oral presentation at the 2017 ASTRO Annual Meeting, San Diego, CA, September 25-27, 2017.
  • Wild A, Fan KY, Dholakia AS, Ford E, Kumar R, Ye X, Tran PT, Grossman SA, Herman JM, Ellsworth SG. Stereotactic body radiation therapy results in less severe treatment-related lymphopenia than conventional chemoradiation therapy in patients with locally advanced pancreatic cancer. Oral presentation at the 2013 ASTRO Annual Meeting, Atlanta, GA, September 22-25, 2013.
  • Dholakia AS, Kumar R, Raman SP, Yovino SG, Wild AT, Fan KY, Hacker-Prietz A, Tran PT, Wolfgang CL, Herman JM. Mapping Patterns of Local Failure Following Pancreaticoduodenectomy for Pancreatic Cancer: A New Approach to Adjuvant Radiation Fields. Oral presentation at the 2013 ASTRO Annual Meeting, Atlanta, GA, September 22-25, 2013.
  • Dholakia AS, Kumar R, Wild AT, Fan KY, Hacker-Prietz A, Ellsworth S, Raman SP, Le DT, Laheru DA, De Jesus-Acosta A, Zheng L, Fishman E, Hruban RH, Weiss MJ, Pawlik TM, Cameron JL, Wolfgang CL, Herman JM. Patterns of local failure following pancreaticoduodenectomy for resectable pancreatic ductal adenocarcinoma. Oral presentation at the 46th Annual Meeting of the Pancreas Club, Orlando, FL, May 17- 18, 2013.
  • Dholakia AS, Fan KY, Wild AT, Hacker-Prietz A, Le DT, De Jesus-Acosta A, Diaz LA, Laheru DA, Hruban RH, Fishman EK, Pawlik TM, Wolfgang CL, Herman JM. Hemoglobin-A1c as a predictor of clinical outcomes in patients seen in a pancreas multidisciplinary cancer clinic. Oral presentation at the American Radium Society 95th Annual Meeting, Scottsdale, AZ, April 27-May 1, 2013.
  • Fan KY, Wild AT, Hacker-Prietz A, Wood L, Blackford AL, Tran PT, Kumar R, Ellsworth S, Dholakia A, Zheng L, Le DT, De Jesus-Acosta A, Rasheed Z, Makary MA, Weiss MJ, Cameron JL, Pawlik TM, Laheru DA, Hruban RH, Fishman EK, Wolfgang CL, Herman JM. Treating pancreatic cancer patients with erlotinib based adjuvant therapy following pancreaticoduodenectomy or pancreatectomy. Oral presentation at the American Radium Society 95th Annual Meeting, Scottsdale, AZ, April 27-May 1, 2013.
  • Kumar R, Ziegler MA, Wild AT, Fan KY, Dholakia AS, Ellsworth S, Pawlik TM, Kamel IR, Herman JM, Geschwind JFH. Efficacy of radioembolization treatments with Yttrium-90 microspheres for liver metastases. Oral presentation at the American Brachytherapy Society 2013 Annual Meeting, New Orleans, LA, April 18-20, 2013.
  • Dholakia AS, Hacker-Prietz A, Wild A, Raman S, Laheru D, Zheng L, Le D, Pawlik T, Makary M, Wolfgang C, De Jesus-Acosta A, Herman J. Radiographic changes associated with surgical resection following neoadjuvant radiation therapy for locally advanced pancreatic adenocarcinoma. Oral presentation at the Americas Hepato-Pancreato-Biliary Association (AHPBA) 2013 Annual Meeting, Miami, FL, February 20-24, 2013.
  • Wild AT, Chang DT, Goodman KM, Laheru DA, Zheng L, Diaz LA, Le DT, Raman SP, Leal JP, Chaudhry MA, Sugar E, Columbo LA, Tom A, Limaye MR, Edil BH, Oteiza K, Hacker-Prietz A, Wolfgang CL, Koong A, Herman JM. A Phase II Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma. Oral presentation at ASTRO’s Cancer Imaging and Radiation Therapy Symposium: A Multidisciplinary Approach, Orlando, FL, February 8-9, 2013. PMID: 24674559.
  • Ziegler MA, Wild AT, Pawlik TM, Laheru DA, Rajasenan T, Wolfgang CL, Herman JM. Assessment of consistency in treatment recommendations among patients seen at a comprehensive pancreatic cancer multidisciplinary clinic. Oral presentation at the American College of Radiology Driving Value into Your Organization Through Quality and Safety Improvements Conference, Scottsdale, AZ, February 17-18, 2012.
  • Wild AT, Begly JP, Garzon-Muvdi J, Desai P, McFarland EG. Chest pain in a female lacrosse player. Oral presentation at the 57th Annual Meeting and Inaugural World Congress on Exercise is Medicine, Baltimore, MD, June 1-5, 2010.